FERTIGYN Injection is a pharmaceutical preparation of human chorionic gonadotropin (hCG) used in a variety of reproductive and hormonal health treatments. hCG is a hormone produced during pregnancy that closely mimics luteinizing hormone (LH) and stimulates the production of sex hormones. In women undergoing fertility therapy, hCG is used to induce ovulation after ovarian stimulation, helping to release mature eggs for procedures such as intrauterine insemination (IUI) or in vitro fertilization (IVF). It also supports the luteal phase by promoting the production of progesterone, essential for embryo implantation and early pregnancy support. In men and adolescent boys, hCG therapy stimulates the testes to produce testosterone, which can treat conditions like hypogonadism or cryptorchidism.
FERTIGYN Injection is available in various strengths; dosing is determined by the healthcare provider based on the individual’s condition. The injection is typically administered by a medical professional, although in some cases patients may be instructed on self-administration. Women usually receive a single injection timed with follicular development, while men may receive injections multiple times per week over several weeks to months. It is critical to follow the physician’s instructions precisely to avoid complications such as ovarian hyperstimulation syndrome (OHSS) in women or hormonal imbalances in men.
Side effects of hCG therapy may include local injection site discomfort, headache, fatigue, irritability, mood swings, or water retention. Women might experience abdominal bloating, breast tenderness or multiple pregnancies; men may experience acne, mood changes or gynecomastia. Individuals with hormone-sensitive cancers, undiagnosed uterine or ovarian conditions, or uncontrolled thyroid or adrenal disorders should avoid hCG therapy.
Consult your healthcare professional to determine if FERTIGYN is appropriate for your fertility or hormone replacement needs and to ensure safe administration.
FERTIGYN Injection is available in various strengths; dosing is determined by the healthcare provider based on the individual’s condition. The injection is typically administered by a medical professional, although in some cases patients may be instructed on self-administration. Women usually receive a single injection timed with follicular development, while men may receive injections multiple times per week over several weeks to months. It is critical to follow the physician’s instructions precisely to avoid complications such as ovarian hyperstimulation syndrome (OHSS) in women or hormonal imbalances in men.
Side effects of hCG therapy may include local injection site discomfort, headache, fatigue, irritability, mood swings, or water retention. Women might experience abdominal bloating, breast tenderness or multiple pregnancies; men may experience acne, mood changes or gynecomastia. Individuals with hormone-sensitive cancers, undiagnosed uterine or ovarian conditions, or uncontrolled thyroid or adrenal disorders should avoid hCG therapy.
Consult your healthcare professional to determine if FERTIGYN is appropriate for your fertility or hormone replacement needs and to ensure safe administration.
0